[
  {
    "question": "A 58-year-old woman with HIV infection is brought to the emergency department because of a 2-week history of headaches, blurred vision, and confusion. Her current medications include antiretroviral therapy and trimethoprim-sulfamethoxazole. Neurological examination shows ataxia and memory impairment. Her CD4+ T-lymphocyte count is 90/\u03bcL. Analysis of her cerebrospinal fluid analysis shows lymphocytic predominant pleocytosis, and PCR is positive for Epstein-Barr virus DNA. An MRI of the brain with contrast shows a solitary, weakly ring-enhancing lesion with well-defined borders involving the corpus callosum. What is the most likely diagnosis?",
    "answer": "A 58-year-old woman with HIV infection is brought to the emergency department because of a 2-week history of headaches, blurred vision, and confusion. Her current medications include antiretroviral therapy and trimethoprim-sulfamethoxazole. Neurological examination shows ataxia and memory impairment. Her CD4+ T-lymphocyte count is 90/\u03bcL. Analysis of her cerebrospinal fluid analysis shows lymphocytic predominant pleocytosis, and PCR is positive for Epstein-Barr virus DNA. An MRI of the brain with contrast shows a solitary, weakly ring-enhancing lesion with well-defined borders involving the corpus callosum. What is the most likely diagnosis? \n**Diagnosis: Primary central nervous system lymphoma**\n\n### Pathogenesis\n\n- The most common primary brain neoplasm in HIV-infected patients\n- Caused by reactivation of Epstein-Barr virus in B lymphocytes due to immunosuppression\n- Characterized by increased Epstein-Barr virus DNA levels in the cerebrospinal fluid\n- A CD4+ T-lymphocyte count < 50/\u03bcL is associated with an increased risk of developing primary central nervous system lymphoma\n\n### Clinical Features\n\n- Symptoms include headaches, confusion, focal neurological deficits (e.g., ataxia, vision impairment)\n- Onset is insidious, but progression is rapid\n\n### Imaging\n\n- On MRI, typically presents as a solitary, ring-enhancing lesion with well-defined borders in the periventricular areas, basal ganglia, and corpus callosum\n- Multiple lesions can be seen\n- Characterized by a lack of edema, mass effect, and surrounding necrosis compared to toxoplasmosis lesions\n- Lesions appear hypointense on T1-weightedimages and isointense or hyperintense on T2-weightedimages\n\n### Differential Diagnoses\n\n- Toxoplasmosis\n  - Toxoplasmosis and primary central nervous system lymphoma both present with ring-enhancing lesions on imaging.\n  - Primary central nervous system lymphomais often located in periventricular areas, while toxoplasmosis typically involves the basal ganglia.\n  - Toxoplasmosis has a higher association with multiple lesions, mass effect, edema, and surrounding necrosis.\n  - Toxoplasmosis is diagnosed by positive toxoplasmosis serology, whereas primary central nervous system lymphomais diagnosed by positive EBV DNA on PCR.\n\n### Treatment\n\n- Combination of chemotherapy (methotrexate and steroids) and highly active antiretroviral therapy(HAART)\n- Response to treatment is poor; the 1-year survival rate is less than 20% in HIV-infected patients.\n",
    "true_answer": "The most likely diagnosis for a patient with HIV, presenting with neurological symptoms and a solitary ring-enhancing lesion, is primary cerebral lymphoma."
  },
  {
    "question": "A 25-year-old sexually active male presents to an internal medicine physician for a routine health check up after having several unprotected sexual encounters. After appropriate testing the physician discusses with the patient that he is HIV+ and must be started on anti-retroviral treatment. What medication prescribed acts on the gp41 subunit of the HIV envelope glycoprotein?",
    "answer": "A 25-year-old sexually active male presents to an internal medicine physician for a routine health check up after having several unprotected sexual encounters. After appropriate testing the physician discusses with the patient that he is HIV+ and must be started on anti-retroviral treatment. What medication prescribed acts on the gp41 subunit of the HIV envelope glycoprotein? \n### Answer:\nEnfuvirtide\n\nEnfuvirtide, also known as T-20, acts on the gp41 subunit of the HIV envelope glycoprotein by interfering with the fusion of the virus to the CD4 cell. This medication is administered subcutaneously every 12 hours and is indicated for use in patients with HIV resistance to multiple antiretrovirals.\n\n### Rationale:\n\nEnfuvirtide (T-20) is the only approved fusion inhibitor. Enfuvirtide, also known as T-20, is the only approved fusion inhibitor. It is a 36-amino acid synthetic peptide that binds to the viral envelope glycoprotein 41 (gp41) subunit. This prevents the viral fusion process, the initial step in HIV replication.\n\nEnfuvirtide is only available as an injection and is administered subcutaneously every 12 hours. Due to its route of administration, enfuvirtide is usually used in combination with other antiretroviral medications for patients with HIV who are resistant to multiple antiretroviral drugs.\n\nSide effects of enfuvirtide include local injection site reactions, which may be severe. Other side effects may include pneumonia, diarrhea, peripheral neuropathy, and nausea. Enfuvirtide is not metabolized by the liver and therefore does not interact with other drugs. It is typically not used in patients with moderate to severe renal dysfunction.",
    "true_answer": "The medication that targets the gp41 subunit of the HIV envelope glycoprotein is enfuvirtide."
  },
  {
    "question": "A mother with HIV has given birth to a healthy boy 2 days ago. She takes her antiretroviral medication regularly and is compliant with the therapy. Before being discharged, her doctor explains that she cannot breastfeed the child since there is a risk of infection through breastfeeding and stresses that the child can benefit from formula feeding. The physician stresses the importance of not overheating the formula since Vitamin C may be inactivated by overheating. What molecular process could be impaired if the mother boiled the formula longer than needed?",
    "answer": "A mother with HIV has given birth to a healthy boy 2 days ago. She takes her antiretroviral medication regularly and is compliant with the therapy. Before being discharged, her doctor explains that she cannot breastfeed the child since there is a risk of infection through breastfeeding and stresses that the child can benefit from formula feeding. The physician stresses the importance of not overheating the formula since Vitamin C may be inactivated by overheating. What molecular process could be impaired if the mother boiled the formula longer than needed? \n\n### Question Analysis\n\nThe question revolves around the molecular process that could be impaired if the mother boils the formula for too long, potentially inactivating Vitamin C. This scenario involves a mother with HIV who is advised against breastfeeding her child due to the risk of transmission. Instead, she is recommended formula feeding, with a caution about not overheating the formula, as Vitamin C can be inactivated by excessive heat.\n\n### Molecular Process: Denaturation\n\nDenaturation is the process by which proteins and other macromolecules lose their quaternary, tertiary, and secondary structure. This loss of structure can occur due to various factors, including:\n\n- Heat\n- Acid\n- Base\n\nDenaturation can render these macromolecules non-functional, making them unable to perform their intended roles within the body.\n\n### Protein Structure and Denaturation\n\n- **Primary Structure:** The sequence of amino acids in a polypeptide chain, determined by the sequence of nucleotides in the DNA template. This structure is relatively resistant to denaturation.\n- **Secondary Structure:** The local arrangements of amino acids, such as alpha helices and beta sheets, stabilized by hydrogen bonds. This structure can be denatured by heat, acid, or base, leading to the loss of hydrogen bonds and the collapse of the secondary structure.\n- **Tertiary Structure:** The overall 3D shape of a single protein molecule, determined by interactions between amino acids. This structure can be denatured by heat, acid, or base, causing the protein to unfold and lose its function.\n- **Quaternary Structure:** The structure formed by several protein molecules (polypeptide chains), which are called protein subunits. This structure can be denatured by heat, acid, or base, causing the subunits to separate and lose their function.\n\n### Answer\n\nThe molecular process that could be impaired if the mother boiled the formula for too long is denaturation of proteins, specifically the loss of their tertiary and quaternary structure due to excessive heat.",
    "true_answer": "If the formula is boiled longer than needed, resulting in the inactivation of Vitamin C, then collagen synthesis could be impaired."
  },
  {
    "question": "A 35-year-old woman presents to a physician\u2019s office for a follow-up visit. She recently underwent a complete physical examination with routine laboratory tests. She also had a Pap smear and testing for sexually transmitted diseases. Since her divorce 2 years ago, she had sexual encounters with random men at bars or social events and frequently did not use any form of protection during sexual intercourse. She was shown to be positive for the human immunodeficiency virus (HIV). Combination anti-retroviral treatment is initiated including zidovudine, didanosine, and efavirenz. One week later, she is rushed to the hospital where she is diagnosed with acute pancreatitis. What precautions in her medication will be required after pancreatitis resolves with treatment?",
    "answer": "A 35-year-old woman presents to a physician\u2019s office for a follow-up visit. She recently underwent a complete physical examination with routine laboratory tests. She also had a Pap smear and testing for sexually transmitted diseases. Since her divorce 2 years ago, she had sexual encounters with random men at bars or social events and frequently did not use any form of protection during sexual intercourse. She was shown to be positive for the human immunodeficiency virus (HIV). Combination anti-retroviral treatment is initiated including zidovudine, didanosine, and efavirenz. One week later, she is rushed to the hospital where she is diagnosed with acute pancreatitis. What precautions in her medication will be required after pancreatitis resolves with treatment? \n\n### Answer:\nStop didanosine.\n\n### Explanation:\nDidanosine (ddI) is a nucleoside reverse transcriptase inhibitor used for the treatment of HIV. However, ddI can cause pancreatitis, which, in turn, can cause pancreatic necrosis and is considered an absolute contraindication for didanosine. Zidovudine and efavirenz can be continued as part of the treatment regimen.\n\n### Reference: \nGoodman and Gilman's: The Pharmacological Basis of Therapeutics, 12th edition",
    "true_answer": "After resolving pancreatitis, didanosine should be replaced with lamivudine to avoid recurrence."
  },
  {
    "question": "A physician scientist is looking for a more efficient way to treat HIV. Patients infected with HIV mount a humoral immune response by producing antibodies against the HIV envelope proteins. These antibodies are the same antibodies detected by the ELISA and western blot assays used to diagnose the disease. The physician scientist is trying to generate a new, more potent antibody against the same HIV envelope proteins targeted by the natural humoral immune response. Of the following proteins, which is the most likely target of the antibody he is designing?",
    "answer": "A physician scientist is looking for a more efficient way to treat HIV. Patients infected with HIV mount a humoral immune response by producing antibodies against the HIV envelope proteins. These antibodies are the same antibodies detected by the ELISA and western blot assays used to diagnose the disease. The physician scientist is trying to generate a new, more potent antibody against the same HIV envelope proteins targeted by the natural humoral immune response. Of the following proteins, which is the most likely target of the antibody he is designing? \n**Understanding the Antibody Response to HIV**\nHIV (Human Immunodeficiency Virus) is a complex virus that triggers a robust immune response in the host. The virus has several proteins on its surface, but the key to understanding the antibody response lies in identifying the primary target of the humoral immune response.\n\n**Key Proteins Involved in the Humoral Immune Response:**\n\n1. **GP120**: This is the primary protein on the surface of HIV that interacts with CD4 receptors on host T cells. It is the target of the initial humoral immune response.\n2. **GP41**: This protein forms the core of the HIV envelope and is involved in the fusion of the viral envelope with the host cell membrane.\n3. **P24**: This protein is a major component of the HIV core and is involved in the assembly of the virus.\n4. **POL**: This protein is involved in the replication of the viral genome.\n5. **P7, P6, P1, P2, Nucleocapsid, VIF, VPR, and VPU**: These proteins are involved in various stages of the viral life cycle, but they are not the primary targets of the humoral immune response.\n\n**The Primary Target of the Humoral Immune Response**\nThe primary target of the humoral immune response is GP120, the protein on the surface of HIV that interacts with CD4 receptors on host T cells. The immune system produces antibodies against GP120 to neutralize the virus and prevent its entry into host cells.\n\n**Reference:** Ray C.G., Ryan K.J. (2010). Chapter 31. Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS). In C.G. Ray, K.J. Ryan (Eds), Sherris Medical Microbiology, 5th edition\n\n### Answer:\nGP120",
    "true_answer": "The most likely target of the antibody being designed for HIV envelope proteins is gp120."
  },
  {
    "question": "A 50-year-old HIV-positive male presents to the ER with a two-day history of fever and hemoptysis. Chest radiograph shows a fibrocavitary lesion in the right middle lobe. Biopsy of the afflicted area demonstrates septate hyphae that branch at acute angles. What is the most likely causal organism?",
    "answer": "A 50-year-old HIV-positive male presents to the ER with a two-day history of fever and hemoptysis. Chest radiograph shows a fibrocavitary lesion in the right middle lobe. Biopsy of the afflicted area demonstrates septate hyphae that branch at acute angles. What is the most likely causal organism? \n\n**Infectious Presentation**\nThe patient presents with fever and hemoptysis, indicating an infectious process within the lungs. The presence of a fibrocavitary lesion in the right middle lobe suggests a chronic or opportunistic infection.\n\n**Chest Radiograph Findings**\n- Fibrocavitary lesions are typically seen in chronic infections, such as tuberculosis or fungal infections.\n- The location in the right middle lobe is common for certain fungal infections.\n\n**Biopsy Findings**\n- Septate hyphae that branch at acute angles are characteristic of certain fungal species.\n- This branching pattern is often seen in Aspergillus species.\n\n**HIV Status**\n- The patient's HIV-positive status indicates a compromised immune system, making him more susceptible to opportunistic infections.\n\n**Common Fungal Infections in Immunocompromised Patients**\n- Aspergillus is a common opportunistic pathogen in immunocompromised patients, particularly those with HIV/AIDS.\n- It can cause invasive aspergillosis, characterized by the formation of a fungus ball (aspergilloma) within pre-existing cavities.\n\n**Conclusion**\nBased on the patient's presentation, radiographic findings, and biopsy results, the most likely causal organism is Aspergillus.\n\n### Answer:\nAspergillus",
    "true_answer": "The most likely causal organism for the symptoms presented is Aspergillus fumigatus."
  },
  {
    "question": "A 43-year-old man with HIV infection comes to the physician because of a 2-week history of progressive diarrhea and a 3-kg (6.6-lb) weight loss. During this period, he has had 3\u20134 episodes of watery stools daily, with multiple instances of blood in the stool. He is currently receiving antiretroviral therapy with zidovudine, lamivudine, and dolutegravir. Physical examination shows pallor and dry mucous membranes. A colonoscopy shows multiple linear ulcers. Polymerase chain reaction of a stool sample is positive for cytomegalovirus. Treatment with valganciclovir is begun. Adding this drug to his current medication regimen puts this patient at greatest risk for what specific adverse effects?",
    "answer": "A 43-year-old man with HIV infection comes to the physician because of a 2-week history of progressive diarrhea and a 3-kg (6.6-lb) weight loss. During this period, he has had 3\u20134 episodes of watery stools daily, with multiple instances of blood in the stool. He is currently receiving antiretroviral therapy with zidovudine, lamivudine, and dolutegravir. Physical examination shows pallor and dry mucous membranes. A colonoscopy shows multiple linear ulcers. Polymerase chain reaction of a stool sample is positive for cytomegalovirus. Treatment with valganciclovir is begun. Adding this drug to his current medication regimen puts this patient at greatest risk for what specific adverse effects?*The drug interaction between valganciclovir and zidovudine is listed above in Table 23-2.Valganciclovir is rapidly metabolized to ganciclovir by esterases in the intestinal wall and plasma. Ganciclovir is active against both human herpes viruses (HSV1, HSV2, VZV, CMV) and retroviruses (HIV). It is usually given IV for treatment of CMV retinitis or colitis in immunocompromised patients. Oral ganciclovir is used as a suppressive drug in some patients after initial IV treatment with ganciclovir. It is available as valganciclovir, which is rapidly converted to ganciclovir in vivo. The drug is phosphorylated by viral kinases to the monophosphate and then by cellular kinases to the triphosphate, which inhibits viral DNA polymerase. Acyclovir-resistant viruses can also be resistant to ganciclovir. Neutropenia is the major dose-limiting toxicity, but ganciclovir causes this less frequently than does zidovudine. In this patient, ganciclovir may enhance zidovudine-induced neutropenia.",
    "true_answer": "Treatment with valganciclovir places the patient at increased risk for pancytopenia."
  },
  {
    "question": "A 28-year-old G1P0 woman at 16 weeks estimated gestational age presents for prenatal care. Routine prenatal screening tests are performed and reveal a positive HIV antibody test. The patient is extremely concerned about the possible transmission of HIV to her baby and wants to have the baby tested as soon as possible after delivery. Which of the following would be the most appropriate diagnostic test to address this patient\u2019s concern?",
    "answer": "A 28-year-old G1P0 woman at 16 weeks estimated gestational age presents for prenatal care. Routine prenatal screening tests are performed and reveal a positive HIV antibody test. The patient is extremely concerned about the possible transmission of HIV to her baby and wants to have the baby tested as soon as possible after delivery. Which of the following would be the most appropriate diagnostic test to address this patient\u2019s concern? (A) HIV-1 p24 antigen detection (B) HIV-1 DNA polymerase chain reaction (PCR) (C) HIV-1 culture (D) HIV-2 antibody detection (E) Western blot\nThe Centers for Disease Control and Prevention (CDC) recommends that all pregnant women be screened for HIV at the first prenatal visit. If the patient is known to be HIV-positive, the neonate will have a positive test for HIV antibodies (the same as the mother) for at least 12 to 18 months. This positive test indicates only that the neonate was exposed to HIV. The HIV antibody tests may be positive in an infected individual even when there are no other clinical signs of infection. The p24 antigen test is a surrogate test for HIV that can be used to follow the progression of the disease and to monitor the effectiveness of antiviral therapy. HIV-1 DNA PCR can be used to diagnose HIV infection in the neonate. However, the test should not be performed immediately after birth because maternal blood may contaminate the specimen. Waiting 1 week after birth minimizes the probability of contamination with maternal blood. HIV-1 culture is a standard method of confirming HIV infection and can be used for diagnostic testing in the neonate. However, culture is expensive and results are not available for 4 to 6 weeks. HIV-2 has a different geographic distribution (West Africa) and a longer incubation period than HIV-1. Most U.S. blood banks do not routinely screen for HIV-2. Western blot is an antibody detection test that is used to confirm HIV positivity after initial testing with a screen-ing test (e.g., ELISA). It does not detect active infection and is inappropriate in neonates because of the presence of maternal antibodies.\n### Answer:\nB",
    "true_answer": "The most appropriate test for early HIV diagnosis in a newborn is the polymerase chain reaction (PCR) for HIV RNA."
  },
  {
    "question": "A 32-year-old man comes to the office for a routine health maintenance examination. He admits to recently having an affair several months ago and requests STD testing. One week later, the results of a fourth-generation HIV antibody and antigen test return positive. The patient is counseled on the test result. The patient requests that his diagnosis not be disclosed to anyone, including his wife. The man's wife is also the physician's patient. What should be the most appropriate next step by the physician?",
    "answer": "A 32-year-old man comes to the office for a routine health maintenance examination. He admits to recently having an affair several months ago and requests STD testing. One week later, the results of a fourth-generation HIV antibody and antigen test return positive. The patient is counseled on the test result. The patient requests that his diagnosis not be disclosed to anyone, including his wife. The man's wife is also the physician's patient. What should be the most appropriate next step by the physician?HIV-positive individuals and their physicians are bound by confidentiality laws. These laws protect the patient and prohibit the disclosure of the positive HIV test without the patient's consent. If the patient refuses to disclose the positive HIV test to the spouse, the physician is not allowed to breach the patient's confidentiality to inform the spouse. However, the physician is obligated to inform the spouse that he or she may be at risk for exposure to an STD and should get tested. In addition, the physician should offer the patient a referral for counseling. A physician who does not have the ability to refer the patient to another physician should contact his or her state's medical board to see if the state's laws supersede HIPAA laws.References: The American Medical Association (AMA) Code of Ethics; The American Academy of Family Physicians (AAFP) Code of Ethics; The American College of Physicians (ACP) Ethics Manual; Centers for Disease Control and Prevention (CDC); The Health Insurance Portability and Accountability Act (HIPAA)The Health Insurance Portability and Accountability Act (HIPAA) of 1996 defines and mandates confidentiality, privacy, and security regulations for health information. HIPAA requires health care providers to have policies, procedures, and documentation for protecting the privacy of health information, including that related to HIV and other sexually transmitted diseases.\nAnswer: A",
    "true_answer": "The physician should report the HIV infection to the national health authorities while maintaining confidentiality per regulations."
  },
  {
    "question": "A 41-year-old HIV-positive male presents to the ER with a 4-day history of headaches and nuchal rigidity. A lumbar puncture shows an increase in CSF protein and a decrease in CSF glucose. When stained with India ink, light microscopy of the patient\u2019s CSF reveals encapsulated yeast with narrow-based buds. Assuming a single pathogenic organism is responsible for this patient\u2019s symptoms, what diagnostic test results would also be expected in this patient?",
    "answer": "A 41-year-old HIV-positive male presents to the ER with a 4-day history of headaches and nuchal rigidity. A lumbar puncture shows an increase in CSF protein and a decrease in CSF glucose. When stained with India ink, light microscopy of the patient\u2019s CSF reveals encapsulated yeast with narrow-based buds. Assuming a single pathogenic organism is responsible for this patient\u2019s symptoms, what diagnostic test results would also be expected in this patient? \n\n### Explanation\n\n#### Clinical Presentation\n\nThe patient presents with symptoms of meningitis, including headaches and nuchal rigidity. The lumbar puncture results show an increase in CSF protein and a decrease in CSF glucose, which are indicative of a bacterial or fungal meningitis. The presence of encapsulated yeast with narrow-based buds in the CSF stained with India ink suggests a fungal infection, specifically Cryptococcus neoformans.\n\n#### Pathogenesis\n\nCryptococcus neoformans is an encapsulated yeast that can cause meningitis, particularly in immunocompromised patients, such as those with HIV/AIDS. The yeast can be found in soil contaminated with bird droppings, and inhalation of spores can lead to pulmonary infection. From there, the fungus can disseminate to the CNS, causing meningitis.\n\n#### Diagnostic Tests\n\nGiven the clinical presentation and the identification of Cryptococcus neoformans in the CSF, the following diagnostic test results would also be expected:\n\n- **Serum and CSF Cryptococcal Antigen**: These tests would be positive, indicating the presence of the fungus in the patient's blood and CSF.\n- **Positive India Ink Staining**: This test is already positive, showing the presence of encapsulated yeast with narrow-based buds in the CSF.\n- **Culture of the Organism**: A culture of the CSF would grow Cryptococcus neoformans, confirming the diagnosis.\n- **Lactate Dehydrogenase (LDH) and Neutrophils in CSF**: These tests are typically not diagnostic for cryptococcal meningitis. However, they may be elevated in other types of meningitis, such as bacterial meningitis.\n\n#### Expected Results\n\n- Serum and CSF Cryptococcal Antigen: Positive\n- Positive India Ink Staining: Already positive\n- Culture of the Organism: Cryptococcus neoformans would grow\n- Lactate Dehydrogenase (LDH) and Neutrophils in CSF: Not diagnostic for cryptococcal meningitis\n\n### Answer:\nSerum and CSF Cryptococcal Antigen",
    "true_answer": "A latex agglutination test specific for Cryptococcal meningitis would also be expected in this patient."
  }
]